Quality control autophagy: a joint effort of ubiquitin, protein deacetylase and actin cytoskeleton.
Abstract
Autophagy has been predominantly studied as a nonselective self-digestion process
that recycles macromolecules and produces energy in response to starvation. However,
autophagy independent of nutrient status has long been known to exist. Recent evidence
suggests that this form of autophagy enforces intracellular quality control by selectively
disposing of aberrant protein aggregates and damaged organelles--common denominators
in various forms of neurodegenerative diseases. By definition, this form of autophagy,
termed quality-control (QC) autophagy, must be different from nutrient-regulated autophagy
in substrate selectivity, regulation and function. We have recently identified the
ubiquitin-binding deacetylase, HDAC6, as a key component that establishes QC. HDAC6
is not required for autophagy activation per se; rather, it is recruited to ubiquitinated
autophagic substrates where it stimulates autophagosome-lysosome fusion by promoting
F-actin remodeling in a cortactin-dependent manner. Remarkably, HDAC6 and cortactin
are dispensable for starvation-induced autophagy. These findings reveal that autophagosomes
associated with QC are molecularly and biochemically distinct from those associated
with starvation autophagy, thereby providing a new molecular framework to understand
the emerging complexity of autophagy and therapeutic potential of this unique machinery.
Type
Journal articleSubject
Actin CytoskeletonAnimals
Autophagy
Disease Models, Animal
Histone Deacetylases
Humans
Lysosomes
Mice
Models, Biological
Neuroprotective Agents
Phagosomes
Ubiquitin
Permalink
https://hdl.handle.net/10161/3964Published Version (Please cite this version)
10.4161/auto.6.4.11812Publication Info
Lee, Joo-Yong; & Yao, Tso-Pang (2010). Quality control autophagy: a joint effort of ubiquitin, protein deacetylase and actin
cytoskeleton. Autophagy, 6(4). pp. 555-557. 10.4161/auto.6.4.11812. Retrieved from https://hdl.handle.net/10161/3964.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Tso-Pang Yao
Professor of Pharmacology and Cancer Biology
My laboratory studies the regulatory functions of protein acetylation in cell signaling
and human disease. We focus on a class of protein deacetylases, HDACs, which we have
discovered versatile functions beyond gene transcription. We wish to use knowledge
of HDAC biology to develop smart and rational clinical strategies for HDAC inhibitors,
a growing class of compounds that show potent anti-tumor and other clinically relevant
activities. Currently, there two major research major areas in the

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info